empower-lung 1: cemiplimab è una nuova opzione terapeutica nel nsclc
Published 3 years ago • 353 plays • Length 11:04Download video MP4
Download video MP3
Similar videos
-
3:15
studio empower-lung 1: una nuova opzione terapeutica in prima linea nel nsclc avanzato
-
6:55
empower lung 1: cemiplimab in prima linea nel nsclc avanzato
-
4:24
aggiornamento a 3 anni dell’empower-lung 1
-
5:26
cemiplimab efficacy by pd-l1 expression in the empower-lung 1 trial of nsclc
-
2:18
empower-lung 1: ctdna as a biomarker for treatment responses in nsclc
-
3:06
roy s. herbst, md, phd, elaborates on the design and outcomes of the empower-lung 1 clinical study
-
2:37
exploratory analysis of frontline therapies in revel: phase 3 trial of ramucirumab in nsclc
-
1:02
novel perioperative strategies for non-small cell lung cancer
-
3:24
2018 lung cancer update for clinicians by the cap-iaslc-amp
-
1:22
dr. horn on updated data from impower133 in small cell lung cancer
-
1:33
dr. anne chiang on molecular testing in lung cancer treatment planning
-
2:49
what is multi-focal lung cancer?
-
1:42
our heroes: trever bivona, md
-
6:30
understanding small cell lung cancer treatment options
-
3:26
sugemalimab plus platinum-based chemotherapy for metastatic non-small-cell lung cancer
-
4:07
lung cancer in 4 minutes (eng)
-
9:54
rimborsato amivantamab anticorpo contro carcinoma polmonare non a piccole cellule con mutazione egfr
-
0:52
addition of trilaciclib may mitigate myelosuppression in patients with small cell lung cancer